Billionaire Profile
Zhong Huijuan
Global Rank
#149

Image: Unsplash Contributor | Unsplash License | via Unsplash

Zhong Huijuan

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$17.968B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+4.39% (24h)
Age
65
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Zhong Huijuan is a prominent Chinese billionaire businesswoman and pharmaceutical executive, recognized as the founder, chairwoman, and CEO of Hansoh Pharmaceutical Group Company Limited. Born in April 1961, she is the world's richest self-made woman, with a net worth of $20.6 billion in 2024, primarily from her 66% stake in Hansoh. Zhong's career began as a chemistry teacher before she transitioned to entrepreneurship, co-founding Hansoh Pharmaceutical in 1995. Under her leadership, Hansoh has become a leading drugmaker. She reinvested a significant portion of revenue into R&D to drive innovation, and has spearheaded lucrative licensing deals. Zhong's story underscores the power of long-term vision and commitment to innovation in the pharmaceutical industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Zhong Huijuan was born in Lianyungang, Jiangsu Province, China, in April 1961. She earned a chemistry degree from Jiangsu Normal University in 1982 and later obtained an EMBA from Nanjing University.

Rise to Success

Zhong began her career as a chemistry teacher at a local middle school. In 1995, she co-founded Hansoh Pharmaceutical with her husband, Sun Piaoyang, and a Hong Kong investor. She transitioned from teaching to become the driving force behind the company. Under her leadership, Hansoh quickly expanded, achieving significant revenue growth by 1997. Zhong prioritized research and development, reinvesting a significant portion of sales into R&D, which led to breakthroughs and international certifications. The company went public on the Hong Kong Stock Exchange in 2019, raising $1 billion.

Key Business Strategies

Zhong's success is attributed to a commitment to innovation and long-term investment in research and development. By focusing on creating unique value, Hansoh has established a strong position in the market. She has also spearheaded lucrative licensing deals with global pharmaceutical giants.

Philanthropy

While specific amounts are not available in the provided search results, it is known that Zhong Huijuan is dedicated to improving patient access. She has helped make life-saving treatment accessible to more patients through innovation and affordability. The company's commitment to research also underlines an element of philanthropic values.

Career Milestones

1982

Graduated from Jiangsu Normal University

Obtained a degree in Chemistry.

1995

Co-founded Hansoh Pharmaceutical

Left teaching to become a founder and run the company.

2019

Hansoh Pharmaceutical IPO

The company went public on the Hong Kong Stock Exchange, raising $1 billion.

2021

Recognized by Forbes

Named the world's 89th richest person, with a net worth of $19.7 billion.

Philanthropy & Social Impact

Healthcare

Focus on Patient Access

Undisclosed

Committed to making life-saving treatments more accessible to patients.

Business Philosophy & Leadership

Notable Quotes

""In 2025, Hansoh Pharma will approach its 30th anniversary, and we will continue to deepen the value of pipeline collaboration, build the foundation for long-term business development, and benefit patients with more breakthrough and high-quality innovative drugs.""

Leadership Principles

Commitment to Innovation

Prioritizing research and development to create unique value.

Long-Term Investment

Focusing on sustainable growth through investment in R&D.